Halozyme(HALO) - 2025 Q2 - Quarterly Results

Exhibit 99.1 Total Revenue Increased 41% YOY to $326 million and Royalty Revenue Increased 65% YOY to $206 million Net Income Increased 77% YOY to $165 million; Adjusted EBITDA Increased 65% YOY to $226 million; GAAP Diluted EPS Increased 85% YOY to $1.33; Non-GAAP Diluted EPS Increased 69% YOY to $1.54 1 Second Quarter and Recent Partner Highlights: HALOZYME RAISES 2025 FINANCIAL GUIDANCE RANGES AND REPORTS STRONG SECOND QUARTER 2025 RESULTS Raising 2025 Financial Guidance Ranges for Total Revenue to $1,27 ...